Chung C, Kudchodkar S, Chung C, Park Y, Xu Z, Pardi N
    
    
    Antibodies (Basel). 2023; 12(3).
  
  
    PMID: 37489368
    
          PMC: 10366852.
    
          DOI: 10.3390/antib12030046.
      
 
                                  
  
    Hollevoet K, Thomas D, Compernolle G, Vermeire G, De Smidt E, De Vleeschauwer S
    
    
    Front Oncol. 2022; 12:1017612.
  
  
    PMID: 36263202
    
          PMC: 9574358.
    
          DOI: 10.3389/fonc.2022.1017612.
      
 
                                  
  
    Hughes D, Hardee J, Waddell D, Goodman C
    
    
    J Appl Physiol (1985). 2022; 133(1):41-59.
  
  
    PMID: 35511722
    
          PMC: 9236869.
    
          DOI: 10.1152/japplphysiol.00088.2022.
      
 
                                  
  
    Pagant S, Liberatore R
    
    
    Pharmaceutics. 2021; 13(11).
  
  
    PMID: 34834297
    
          PMC: 8618954.
    
          DOI: 10.3390/pharmaceutics13111882.
      
 
                                  
  
    Ueda N, Cahen M, Danger Y, Moreaux J, Sirac C, Cogne M
    
    
    Blood Adv. 2021; 5(6):1770-1779.
  
  
    PMID: 33755093
    
          PMC: 7993091.
    
          DOI: 10.1182/bloodadvances.2020003792.
      
 
                              
              
                              
                                      
  Advancements in mRNA Encoded Antibodies for Passive Immunotherapy.
  
    Deal C, Carfi A, Plante O
    
    
    Vaccines (Basel). 2021; 9(2).
  
  
    PMID: 33572679
    
          PMC: 7910832.
    
          DOI: 10.3390/vaccines9020108.
      
 
                                          
                                                          
  In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies.
  
    Andrews C, Huang Y, Ho D, Liberatore R
    
    
    Emerg Microbes Infect. 2020; 9(1):1523-1533.
  
  
    PMID: 32579067
    
          PMC: 7473320.
    
          DOI: 10.1080/22221751.2020.1787108.
      
 
                                          
                                                          
  Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines.
  
    Mucker E, Karmali P, Vega J, Kwilas S, Wu H, Joselyn M
    
    
    Sci Rep. 2020; 10(1):8764.
  
  
    PMID: 32472093
    
          PMC: 7260227.
    
          DOI: 10.1038/s41598-020-65059-0.
      
 
                                          
                                                          
  In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies.
  
    Patel A, Bah M, Weiner D
    
    
    BioDrugs. 2020; 34(3):273-293.
  
  
    PMID: 32157600
    
          PMC: 7211204.
    
          DOI: 10.1007/s40259-020-00412-3.
      
 
                                          
                                                          
  Prolonged  expression and anti-tumor response of DNA-based anti-HER2 antibodies.
  
    Hollevoet K, De Smidt E, Geukens N, Declerck P
    
    
    Oncotarget. 2018; 9(17):13623-13636.
  
  
    PMID: 29568382
    
          PMC: 5862603.
    
          DOI: 10.18632/oncotarget.24426.
      
 
                                          
                                                          
  Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.
  
    Walker L, Burton D
    
    
    Nat Rev Immunol. 2018; 18(5):297-308.
  
  
    PMID: 29379211
    
          PMC: 5918154.
    
          DOI: 10.1038/nri.2017.148.
      
 
                                          
                                                          
  In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections.
  
    Andrews C, Luo Y, Sun M, Yu J, Goff A, Glass P
    
    
    Mol Ther Methods Clin Dev. 2017; 7:74-82.
  
  
    PMID: 29034261
    
          PMC: 5633264.
    
          DOI: 10.1016/j.omtm.2017.09.003.
      
 
                                          
                                                          
  An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model.
  
    Patel A, DiGiandomenico A, Keller A, Smith T, Park D, Ramos S
    
    
    Nat Commun. 2017; 8(1):637.
  
  
    PMID: 28935938
    
          PMC: 5608701.
    
          DOI: 10.1038/s41467-017-00576-7.
      
 
                                          
                                                          
  Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination.
  
    Sanders J, Ponzio T
    
    
    Trop Dis Travel Med Vaccines. 2017; 3:3.
  
  
    PMID: 28883973
    
          PMC: 5531025.
    
          DOI: 10.1186/s40794-017-0046-0.
      
 
                                          
                                                          
  State of play and clinical prospects of antibody gene transfer.
  
    Hollevoet K, Declerck P
    
    
    J Transl Med. 2017; 15(1):131.
  
  
    PMID: 28592330
    
          PMC: 5463339.
    
          DOI: 10.1186/s12967-017-1234-4.
      
 
                                          
                                                          
  Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.
  
    Flingai S, Plummer E, Patel A, Shresta S, Mendoza J, Broderick K
    
    
    Sci Rep. 2015; 5:12616.
  
  
    PMID: 26220099
    
          PMC: 4518257.
    
          DOI: 10.1038/srep12616.
      
 
                                          
                                                          
  Engineering humoral immunity as prophylaxis or therapy.
  
    Deal C, Balazs A
    
    
    Curr Opin Immunol. 2015; 35:113-22.
  
  
    PMID: 26183209
    
          PMC: 4553141.
    
          DOI: 10.1016/j.coi.2015.06.014.
      
 
                                          
                                                          
  Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.
  
    Kudrna J, Ugen K
    
    
    Hum Vaccin Immunother. 2015; 11(8):1921-6.
  
  
    PMID: 26125436
    
          PMC: 4635842.
    
          DOI: 10.1080/21645515.2015.1065364.
      
 
                                          
                                                          
  DNA vaccines: MHC II-targeted vaccine protein produced by transfected muscle fibres induces a local inflammatory cell infiltrate in mice.
  
    Lovas T, Bruusgaard J, Oynebraten I, Gundersen K, Bogen B
    
    
    PLoS One. 2014; 9(10):e108069.
  
  
    PMID: 25299691
    
          PMC: 4191975.
    
          DOI: 10.1371/journal.pone.0108069.
      
 
                                          
                                                          
  Passive immunization against HIV/AIDS by antibody gene transfer.
  
    Yang L, Wang P
    
    
    Viruses. 2014; 6(2):428-47.
  
  
    PMID: 24473340
    
          PMC: 3939464.
    
          DOI: 10.3390/v6020428.